Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Rolland

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Plos Pathogens|December 6, 2023
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United StatesLindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Viruses|July 7, 2019
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy AssessmentRaabya Rossenkhan, Morgane Rolland, Jan P L Labuschagne, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Plos Pathogens|December 6, 2023
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United StatesLindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Viruses|July 7, 2019
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy AssessmentRaabya Rossenkhan, Morgane Rolland, Jan P L Labuschagne, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Pageof 12